Eliane SchutteActing Chief Executive Officer
Eliane Schutte brings to Xeltis extensive expertise in regulatory affairs and global product development in medical devices. With over 20 years of experience in the biotech industry, she joins from The Medicines Company where she was vice president for global product development in the peri-operative care space. Schutte was previously chief development officer at Profibrix, a Dutch-US biotech start-up acquired by The Medicines Company and vice president for regulatory affairs and EU operations at IsoTis Orthobiologics. She is a member of the European medical device trade association EUCOMED and holds a Regulatory Affairs Certification.